Cargando…
Ginkgo Flavonol Glycosides or Ginkgolides Tend to Differentially Protect Myocardial or Cerebral Ischemia–Reperfusion Injury via Regulation of TWEAK-Fn14 Signaling in Heart and Brain
Shuxuening injection (SXNI), one of the pharmaceutical preparations of Ginkgo biloba extract, has significant effects on both ischemic stroke and heart diseases from bench to bedside. Its major active ingredients are ginkgo flavonol glycosides (GFGs) and ginkgolides (GGs). We have previously reported...
Autores principales: | Xiao, Guangxu, Lyu, Ming, Wang, Yule, He, Shuang, Liu, Xinyan, Ni, Jingyu, Li, Lan, Fan, Guanwei, Han, Jihong, Gao, Xiumei, Wang, Xiaoying, Zhu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624656/ https://www.ncbi.nlm.nih.gov/pubmed/31333457 http://dx.doi.org/10.3389/fphar.2019.00735 |
Ejemplares similares
-
TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013) -
Influence of Mineral Supplementation on the Results from Analysis of Flavonol Glycoside Content in Ginkgo biloba Dietary Supplements
por: Lee, Jae-Kyoo, et al.
Publicado: (2019) -
TWEAK/Fn14 Activation Participates in Skin Inflammation
por: Liu, Qilu, et al.
Publicado: (2017) -
A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway
por: Bhattacharjee, Mitali, et al.
Publicado: (2012) -
Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway
por: Stock, Ariel D., et al.
Publicado: (2013)